Additionally, the study shows that NPC1L1 is upregulated in high-stage RCC compared to low-stage RCC, providing insights into how RCC progression may involve cholesterol metabolism and emphasizing the need for further investigation into the role of NPC1L1 in RCC progression. This evidence concerns the gene NPC1L1 and renal cell carcinoma.